FDA PMA FDA Class 3 Approved 🇺🇸 United States

Defibrillator, Automatic Implantable Cardioverter, With Cardiac Resynchronization (Crt-D)

PMA: P010012 · Supplement: S570 · Decision Oct 19, 2023
Classifications
1
FEI Numbers
26
Registration Numbers
26

Basic Information

Device Name
Defibrillator, Automatic Implantable Cardioverter, With Cardiac Resynchronization (Crt-D)
Trade Name
Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy (MADIT-CRT)
PMA Number
P010012
Supplement Number
S570
Device Class
FDA Class 3
Product Code
NIK
Generic Name
Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (CRT-D)
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
Approved
Decision Code
APPR
Decision Date
October 19, 2023
Date Received
May 8, 2023
Supplement Type
Normal 180 Day Track No User Fee
Supplement Reason
Labeling Change - Indications/instructions/shelf life/tradename
Expedited Review
N

Advisory Committee Statement

updated labeling to include information regarding the Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy (MADIT-CRT) Post Approval Studies [ (PAS 1) PAS for the MADIT-CRT Indicated Patient Population, Utilizing Data from the NCDR ICD Registry; (PAS 2) Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy Post Approval Registry]

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
NIK Defibrillator, Automatic Implantable Cardioverter, With Cardiac Resynchronization (Crt-D)